New Tech Targets Cancer's Shared Weakness
Scientists have unveiled PerturbFate, a groundbreaking technology designed to pinpoint crucial "control hubs" within cells where diverse disease-causing genetic mutations, including those linked to cancer and Alzheimer's, converge. This innovative approach promises to revolutionize medicine by targeting these shared cellular vulnerabilities, offering a new path to treat conditions beyond individual faulty genes.